The prevalence of sexual dysfunction among male patients on methadone and buprenorphine treatments: a meta-analysis study

The Journal of Sexual Medicine
Anne YeeChong Guan Ng

Abstract

For many years, methadone has been recognized as an effective maintenance treatment for opioid dependence. However, of the many adverse events reported, sexual dysfunction is one of the most common side effects. We conducted a meta-analysis to evaluate the prevalence of sexual dysfunction among male patients on methadone and buprenorphine treatments. Relevant studies published from inception until December 2012 were identified by searching PubMed, OVID, and Embase. Studies were selected using prior defined criteria. Heterogeneity, publication bias, and odds ratio were assessed thoroughly. To examine the prevalence and odds ratio of sexual dysfunctions among the methadone and buprenorphine groups. A total of 1,570 participants from 16 eligible studies were identified in this meta-analysis. The studies provided prevalence estimates for sexual dysfunction among methadone users with a meta-analytical pooled prevalence of 52% (95% confidence interval [CI], 0.39-0.65). Only four studies compared sexual dysfunction between the two groups, with a significantly higher combined odds ratio in the methadone group (OR = 4.01, 95% CI, 1.52-10.55, P = 0.0049). Evidence showed that the prevalence of sexual dysfunction was higher among the user...Continue Reading

References

Jan 1, 1977·The American Journal of Drug and Alcohol Abuse·R HanburyB Stimmel
Apr 24, 1975·The New England Journal of Medicine·T J CiceroE Robins
Feb 1, 1992·British Journal of Addiction·J BellK Byth
Nov 11, 1992·The International Journal of the Addictions·W D SpringT L Maddux
Sep 1, 1991·American Journal of Public Health·S R YancovitzJ W Robinson
Sep 1, 1988·Journal of Health and Social Behavior·J C BallS R Friedman
Nov 1, 1981·Drug and Alcohol Dependence·S LafiscaM Marigo
Jun 1, 1981·Drug and Alcohol Dependence·L M Gunne, L Grönbladh
Sep 1, 1981·Archives of General Psychiatry·W H McGlothlin, M D Anglin
Aug 18, 1994·The New England Journal of Medicine·P G O'ConnorR S Schottenfeld
Oct 1, 1993·Drug and Alcohol Dependence·D M NovickM J Kreek
Nov 4, 2000·The New England Journal of Medicine·R E JohnsonG E Bigelow
May 10, 2001·American Journal of Public Health·M W LangendamE J van Ameijden
Sep 26, 2002·Journal of Addictive Diseases·Harry W Daniell
Dec 21, 2002·International Journal of Impotence Research·J PrinsJ L H R Bosch
May 10, 2003·Drug and Alcohol Dependence·Sharon L Walsh, Thomas Eissenberg
Oct 16, 2004·The Journal of Clinical Endocrinology and Metabolism·Niclaas BliesenerDietrich Klingmüller
Mar 24, 2005·Journal of Addictive Diseases·Randy BrownMichael Fleming
Jan 1, 1994·Drug and Alcohol Review·J WardW Hall
Dec 18, 2007·Drug and Alcohol Dependence·Gianluca QuaglioUNKNOWN G.I.C.S
Dec 21, 2007·The Journal of Sexual Medicine·Richard HallinanJohn Attia
Mar 9, 2010·Journal of Substance Abuse Treatment·Kenneth M Dürsteler-MacFarlandGerhard A Wiesbeck
Oct 7, 2010·Journal of Addictive Diseases·Patricia A CioeMichael D Stein
Mar 1, 2013·The Journal of Sexual Medicine·Nik Ruzyanei Nik JaafarHatta Sidi
Jul 24, 2013·Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists·Azlin BaharudinNik Ruzyanei Nik Jaafar
Jan 1, 1998·International Journal of Psychiatry in Clinical Practice·M D WaldingerB Olivier

❮ Previous
Next ❯

Citations

Mar 5, 2015·Drug and Alcohol Review·Paxton BachEvan Wood
May 3, 2016·The Urologic Clinics of North America·Anna Ross, Shalender Bhasin
May 5, 2017·Substance Use & Misuse·Jales ClementeJair de Jesus Mari
Apr 11, 2017·British Journal of Pharmacology·Lauri Nummenmaa, Lauri Tuominen
Dec 1, 2017·PloS One·Fabio LugoboniUNKNOWN Gruppo InterSERT di Collaborazione Scientifica (GICS)
Mar 2, 2018·American Journal of Men's Health·Anne YeeAhmad Hatim Sulaiman
Oct 19, 2016·Journal of Addiction Medicine·Joni Bing Fei TeohAhmad Hatim Bin Sulaiman
Oct 28, 2019·Annals of General Psychiatry·Anne YeeAhmad Hatim Bin Sulaiman
Feb 1, 2020·Indian Journal of Psychiatry·Surendra K MattooMahendra Prakash Sharma
Nov 20, 2020·Neuropsychiatric Disease and Treatment·Engin Emrem BestepeGökçe Elif Sarıdoğan
Nov 18, 2020·Substance Abuse Treatment, Prevention, and Policy·David MedvedAshley Elizabeth Muller
Jun 13, 2018·Drug and Alcohol Dependence·M Eugenia SocíasM-J Milloy
Apr 15, 2021·Harm Reduction Journal·Juan J Ruíz RuízUNKNOWN ANDOPIO Study Group
Nov 24, 2021·Cognitive, Affective & Behavioral Neuroscience·Lauri NummenmaaVesa Putkinen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.